Cutera, Inc.

  • Market Cap: Micro Cap
  • Industry: Medical Specialties
  • ISIN: US2321091082
USD
0.01
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Cutera, Inc. stock-summary
stock-summary
Cutera, Inc.
Medical Specialties
Cutera, Inc. is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers. Each of its laser and other energy-based platforms consists of one or more hand pieces and a console that incorporates a universal graphical user interface, a laser or other energy-based module, control system software and high voltage electronics. The Company also offers products, such as CoolGlide that includes CV, Excel and Vantage; Solera that includes Titan S, ProWave 770, OPS 600, LP560, AcuTip 500, Titan V/XL and LimeLight, and a third-party sourced system, myQ for the Japanese market.
Company Coordinates stock-summary
Company Details
3240 Bayshore Blvd , BRISBANE CA : 94005-1021
stock-summary
Tel: 1 415 65755001 415 6575500
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 51 Schemes (37.31%)

Foreign Institutions

Held by 57 Foreign Institutions (7.8%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. J. Daniel Plants
Independent Chairman of the Board
Mr. David Mowry
Chief Executive Officer, Director
Mr. Gregory Barrett
Independent Director
Mr. Timothy O'Shea
Independent Director
Mr. Joseph Whitters
Independent Director
Ms. Katherine Zanotti
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
32 Million
(Quarterly Results - Sep 2024)
Net Profit:
-39 Million
stock-summary
Industry

Medical Specialties

stock-summary
Market cap

USD 0 Million (Micro Cap)

stock-summary
P/E

0

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-1.45

stock-summary
Return on Equity

55.92%

stock-summary
Price to Book

-0.00